Ignite Creation Date:
2025-12-24 @ 3:05 PM
Ignite Modification Date:
2026-01-20 @ 2:01 AM
Study NCT ID:
NCT07007559
Status:
RECRUITING
Last Update Posted:
2025-12-09
First Post:
2025-05-22
Is Gene Therapy:
True
Has Adverse Events:
False
Brief Title:
ASPEN-09: A Study of Evorpacept in Combination With Anti-cancer Therapies in Advanced / Metastatic Malignancies
Sponsor:
ALX Oncology Inc.
Organization:
Organization Data
Organization:
Class:
INDUSTRY
Study ID:
AT148009
Study Type:
None
Study Domain:
None
Study Link:
None
Lead Sponsor:
Lead Sponsor Class:
INDUSTRY
Responsible Party:
Responsible Party Title:
Responsible Party Type:
SPONSOR
Responsible Party Affiliation:
Old Name:
None
Old Organization:
None